Showing results (141-150 of 158) with videos related to
Sort By:
Pageof 16
Journal of Medicinal Chemistry|June 25, 2005
1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activitiesRonghui Lin, Peter J Connolly, Shenlin Huang, et al.Journal of Pain and Symptom Management|January 12, 2024
Examining Moderation of Dignity Therapy Effects by Symptom Burden or Religious/Spiritual StrugglesGeorge Fitchett, Yingwei Yao, Linda L Emanuel, et al.Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agentsRonghui Lin, Peter J Connolly, Yanhua Lu, et al.Journal of Palliative Medicine|September 6, 2022
Death Anxiety and Correlates in Cancer Patients Receiving Palliative CareLinda L Emanuel, Sheldon Solomon, Harvey Max Chochinov, et al.Journal of Palliative Medicine|October 14, 2009
Feasibility and effectiveness of the NEST13+ as a screening tool for advanced illness care needsKaren G Scandrett, Eva B Reitschuler-Cross, Lauren Nelson, et al.Bioorganic & Medicinal Chemistry Letters|July 26, 2008
4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitorsGuozhang Xu, Marta C Abad, Peter J Connolly, et al.Journal of Medicinal Chemistry|January 14, 2015
Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activityHeidi L Perez, Charu Chaudhry, Stuart L Emanuel, et al.Klinicheskaia Laboratornaia Diagnostika|February 5, 2016
[THE CLINICAL LABORATORY MARKERS OF ATHEROSCLEROSIS IN PATIENTS WITH ATHEROTHROMBOTIC STROKE]L N Solovyeva, A A Shmonin, Yu V Emanuel, et al.Bioorganic & Medicinal Chemistry Letters|April 20, 2005
3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluationRonghui Lin, Yanhua Lu, Steven K Wetter, et al.Bioorganic & Medicinal Chemistry Letters|May 8, 2007
4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: synthesis and biological evaluationTerry V Hughes, Stuart L Emanuel, Amanda K Beck, et al.Pageof 16